Adam S. Kibel
Brigham and Women's Hospital
665 Papers
3.4K Citations
Adam S. Kibel is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Prostate cancer & Medicine. The author has an hindex of 65, co-authored 523 publications. Previous affiliations of Adam S. Kibel include Beth Israel Deaconess Medical Center & Harvard University.
Chat about Author
Papers
The effect of limited english proficiency on prostate-specific antigen screening in American men
Benjamin V. Stone,Muhieddine Labban,E. Beatrici,D. K. Filipas,N. Frego,Zhiyu Qian,Sandeep Voleti,Nora Y. Osman,Mark M. Pomerantz,S. R. Lipsitz,Adam S. Feldman,Adam S. Kibel,Alexander P. Cole,Q. Trinh +13 more
TL;DR: Limited English proficiency is associated with significantly lower prevalence of PSA screening among men in the USA, and interventions to mitigate disparities in prostate cancer outcomes should account for limited English proficiency among the barriers to guideline-concordant care.
Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.
Florian Rumpf,Anna Plym,J. Bailey Vaselkiv,Kathryn L. Penney,Mark A. Preston,Adam S. Kibel,Lorelei A. Mucci,K. Salari +7 more
TL;DR: Family history of prostate, breast, or pancreatic cancer and/or a 19q13 germline risk allele are associated with an elevated risk of prostate cancer‒specific death among favorable-risk patients and have implications for how family history and germline genetic risk SNPs should be factored into clinical decision-making around favorable-risk prostate cancer.
Generalizability of established prostate cancer risk variants in men of African ancestry
Ying Han,Lisa B. Signorello,Sara S. Strom,Rick A. Kittles,Benjamin A. Rybicki,Janet L. Stanford,Phyllis J. Goodman,Sonja I. Berndt,John D. Carpten,Graham Casey,Lisa Chu,David V. Conti,Kristin A. Rand,W. Ryan Diver,Anselm Hennis,Esther M. John,Esther M. John,Adam S. Kibel,Eric A. Klein,Suzanne Kolb,Loic Le Marchand,M. Cristina Leske,Adam B. Murphy,Christine Neslund-Dudas,Jong Y. Park,Curtis A. Pettaway,Timothy R. Rebbeck,Susan M. Gapstur,S. Lilly Zheng,Suh Yuh Wu,John S. Witte,Jianfeng Xu,William B. Isaacs,Sue A. Ingles,Ann W. Hsing,Ann W. Hsing,Douglas F. Easton,Rosalind A. Eeles,Fredrick R. Schumacher,Stephen J. Chanock,Barbara Nemesure,William J. Blot,Daniel O. Stram,Brian E. Henderson,Christopher A. Haiman +44 more
TL;DR: In this paper, the authors examined 82 previously reported risk variants in 4,853 prostate cancer cases and 4,678 controls of African ancestry and performed association testing for each variant using logistic regression adjusted for age, study and global ancestry.
Assessment of Out-of-Pocket Costs for Robotic Cancer Surgery in US Adults.
Junaid Nabi,David F. Friedlander,Xi Chen,Alexander P. Cole,Jim C. Hu,Adam S. Kibel,Prokar Dasgupta,Quoc-Dien Trinh +7 more
- 03 Jan 2020
TL;DR: For the 5 procedures investigated, robotic cancer surgery may be more affordable for patients, highlighting an array of economic factors associated with the rapid adoption of this technology.
Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial
John L. Gore,Marguerite du Plessis,Jingbin Zhang,Darlene L.Y. Dai,Darby J. S. Thompson,Lawrence Karsh,Brian R. Lane,Michael E. Franks,David Y.T. Chen,Fernando J. Bianco,Gordon D. Brown,William Clark,Adam S. Kibel,Hyung L. Kim,William T. Lowrance,Murugesan Manoharan,Paul Maroni,Scott Perrapato,Paul Sieber,Edouard J. Trabulsi,Robert J. Waterhouse,Daniel E. Spratt,Elai Davicioni,Yair Lotan,Daniel W. Lin +24 more
TL;DR: Use of Decipher postradical prostatectomy test was associated with postoperative treatment decisions and was an independent predictor for change in management for both adjuvant and salvage patients.